• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高泌乳素血症性性腺功能减退男性的骨质疏松症

Osteoporosis in men with hyperprolactinemic hypogonadism.

作者信息

Greenspan S L, Neer R M, Ridgway E C, Klibanski A

出版信息

Ann Intern Med. 1986 Jun;104(6):777-82. doi: 10.7326/0003-4819-104-6-777.

DOI:10.7326/0003-4819-104-6-777
PMID:3706929
Abstract

To ascertain the effects of chronic hyperprolactinemia and testosterone deficiency on skeletal integrity in men, we measured forearm bone density and hormone concentrations in 18 men aged 30 to 79 who had prolactin-secreting pituitary tumors. We also measured vertebral bone density in 12 of the men. Patients with hyperprolactinemia had significant decreases in both forearm (p less than 0.001) and vertebral bone density (p = 0.003) compared with age-matched controls. Cortical osteopenia was significantly related to the duration of hyperprolactinemia (p less than 0.01) but not to the absolute levels of prolactin or androgens. Seven patients had longitudinal follow-up measurements of forearm bone density. Normalization of serum levels of prolactin or testosterone was associated with an increase in forearm bone density (p less than 0.05). These data show that chronic hyperprolactinemia and testosterone deficiency in men have deleterious and previously unrecognized extragonadal effects that may be alleviated after normalization of hormone concentrations.

摘要

为确定慢性高泌乳素血症和睾酮缺乏对男性骨骼完整性的影响,我们测量了18名年龄在30至79岁、患有分泌泌乳素的垂体瘤男性的前臂骨密度和激素浓度。我们还测量了其中12名男性的脊椎骨密度。与年龄匹配的对照组相比,高泌乳素血症患者的前臂骨密度(p<0.001)和脊椎骨密度(p = 0.003)均显著降低。皮质骨减少与高泌乳素血症的持续时间显著相关(p<0.01),但与泌乳素或雄激素的绝对水平无关。7名患者接受了前臂骨密度的纵向随访测量。泌乳素或睾酮血清水平的正常化与前臂骨密度增加相关(p<0.05)。这些数据表明,男性慢性高泌乳素血症和睾酮缺乏具有有害的、以前未被认识到的性腺外效应,激素浓度正常化后这些效应可能会得到缓解。

相似文献

1
Osteoporosis in men with hyperprolactinemic hypogonadism.高泌乳素血症性性腺功能减退男性的骨质疏松症
Ann Intern Med. 1986 Jun;104(6):777-82. doi: 10.7326/0003-4819-104-6-777.
2
Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism.
Ann Intern Med. 1989 Apr 1;110(7):526-31. doi: 10.7326/0003-4819-110-7-526.
3
Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism.一名患有高催乳素血症性腺功能减退症男性的症状性骨质疏松症。
Ann Intern Med. 1986 Oct;105(4):543-5. doi: 10.7326/0003-4819-105-4-543.
4
Vertebral fractures in males with prolactinoma.男性催乳素瘤患者的椎体骨折。
Endocrine. 2011 Jun;39(3):288-93. doi: 10.1007/s12020-011-9462-5. Epub 2011 Apr 10.
5
Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.溴隐亭治疗期间高泌乳素血症女性的血浆降钙素、胰岛素样生长因子-I水平及椎骨骨密度
Acta Endocrinol (Copenh). 1993 May;128(5):423-7. doi: 10.1530/acta.0.1280423.
6
[Prolactinomas and bone mineral density in men].[男性泌乳素瘤与骨矿物质密度]
Arq Bras Endocrinol Metabol. 2005 Apr;49(2):183-95. doi: 10.1590/s0004-27302005000200004. Epub 2005 Sep 12.
7
Long-term follow-up of 246 hyperprolactinemic patients.246例高催乳素血症患者的长期随访
Acta Obstet Gynecol Scand. 2001 Feb;80(2):162-8. doi: 10.1034/j.1600-0412.2001.080002162.x.
8
Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.精神疾病和精神药物对催乳素及骨代谢的影响。
J Clin Psychiatry. 2004 Dec;65(12):1607-18; quiz 1590, 1760-1. doi: 10.4088/jcp.v65n1205.
9
Prolactin-secreting tumors and hypogonadism in 22 men.
N Engl J Med. 1978 Oct 19;299(16):847-52. doi: 10.1056/NEJM197810192991602.
10
Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea.
J Clin Endocrinol Metab. 1987 May;64(5):1021-6. doi: 10.1210/jcem-64-5-1021.

引用本文的文献

1
PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men.PRDM16通过经典WNT10b/β-连环蛋白途径增强睾酮治疗的性腺功能减退男性的成骨RUNX2。
Biomolecules. 2025 Jan 8;15(1):79. doi: 10.3390/biom15010079.
2
Modern approach to bone comorbidity in prolactinoma.泌乳素瘤骨合并症的现代研究方法。
Pituitary. 2024 Dec;27(6):802-812. doi: 10.1007/s11102-024-01469-x. Epub 2024 Nov 14.
3
Skeletal fragility in pituitary disease: how can we predict fracture risk?垂体疾病中的骨骼脆性:我们如何预测骨折风险?
Pituitary. 2024 Dec;27(6):789-801. doi: 10.1007/s11102-024-01447-3. Epub 2024 Sep 6.
4
Impact of medical therapy for hormone-secreting Pituitary tumors on bone.激素分泌型垂体瘤的药物治疗对骨骼的影响。
Pituitary. 2024 Dec;27(6):860-873. doi: 10.1007/s11102-024-01421-z. Epub 2024 Jul 5.
5
Pituitary macroadenoma with panhypopituitarism masquerading as schizophrenia: a diagnostic dilemma managed conservatively.垂体大腺瘤伴全垂体功能减退伪装成精神分裂症:一例保守治疗的诊断难题
Ann Med Surg (Lond). 2023 Oct 17;85(12):6247-6251. doi: 10.1097/MS9.0000000000001413. eCollection 2023 Dec.
6
Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review.性腺功能减退症、2 型糖尿病和骨骼健康:叙述性综述。
Front Endocrinol (Lausanne). 2021 Jan 18;11:607240. doi: 10.3389/fendo.2020.607240. eCollection 2020.
7
Dihydrotestosterone and 17-Estradiol Enhancement of in vitro Osteogenic Differentiation of Castrated Male Rat Bone Marrow Mesenchymal Stem Cells (rBMMSCs).双氢睾酮和17-β-雌二醇对去势雄性大鼠骨髓间充质干细胞(rBMMSCs)体外成骨分化的促进作用
Int J Hematol Oncol Stem Cell Res. 2019 Oct 1;13(4):208-219.
8
Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy.雄激素和雄激素受体对骨骼健康和疾病的作用:从雄激素缺乏到雄激素治疗。
Cells. 2019 Oct 25;8(11):1318. doi: 10.3390/cells8111318.
9
Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health.男性性腺功能减退与骨质疏松症:睾酮缺乏对骨骼健康的影响、临床后果及治疗
Int J Endocrinol. 2017;2017:4602129. doi: 10.1155/2017/4602129. Epub 2017 Mar 16.
10
Hypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover.患有2型糖尿病的性腺功能减退男性骨尺寸较小且骨转换率较低。
Bone. 2017 Jun;99:14-19. doi: 10.1016/j.bone.2017.03.039. Epub 2017 Mar 16.